These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23291341)

  • 1. Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes.
    Ramos-Álvarez I; Martín-Duce A; Moreno-Villegas Z; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):109-15. PubMed ID: 23291341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of bombesin receptor Subtype-3 by [D-Tyr
    Moreno-Villegas Z; Martín-Duce A; Aparicio C; Portal-Núñez S; Sanz R; Mantey SA; Jensen RT; Lorenzo O; Egido J; González N
    Mol Cell Endocrinol; 2018 Oct; 474():10-19. PubMed ID: 29402494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes.
    Ramos-Álvarez I; Moreno-Villegas Z; Martín-Duce A; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
    Peptides; 2014 Jan; 51():91-9. PubMed ID: 24220502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes.
    González N; Martín-Duce A; Martínez-Arrieta F; Moreno-Villegas Z; Portal-Núñez S; Sanz R; Egido J
    Int J Mol Med; 2015 Apr; 35(4):925-31. PubMed ID: 25653074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and pharmacology of bombesin receptor subtype-3.
    Majumdar ID; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin receptor subtype 3 as a potential target for obesity and diabetes.
    González N; Moreno P; Jensen RT
    Expert Opin Ther Targets; 2015; 19(9):1153-70. PubMed ID: 26066663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice.
    Nakamichi Y; Wada E; Aoki K; Ohara-Imaizumi M; Kikuta T; Nishiwaki C; Matsushima S; Watanabe T; Wada K; Nagamatsu S
    Biochem Biophys Res Commun; 2004 Jun; 318(3):698-703. PubMed ID: 15144894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
    Ladenheim EE; Hamilton NL; Behles RR; Bi S; Hampton LL; Battey JF; Moran TH
    Endocrinology; 2008 Mar; 149(3):971-8. PubMed ID: 18039774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
    González N; Acitores A; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
    Regul Pept; 2005 Mar; 126(3):203-11. PubMed ID: 15664668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of oridonin as a novel agonist for BRS-3.
    Zhu Y; Wu L; Zhao Y; Wang Z; Lu J; Yu Y; Xiao H; Zhang Y
    Phytomedicine; 2022 Jun; 100():154085. PubMed ID: 35405616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity.
    Guan XM; Chen H; Dobbelaar PH; Dong Y; Fong TM; Gagen K; Gorski J; He S; Howard AD; Jian T; Jiang M; Kan Y; Kelly TM; Kosinski J; Lin LS; Liu J; Marsh DJ; Metzger JM; Miller R; Nargund RP; Palyha O; Shearman L; Shen Z; Stearns R; Strack AM; Stribling S; Tang YS; Wang SP; White A; Yu H; Reitman ML
    Cell Metab; 2010 Feb; 11(2):101-12. PubMed ID: 20096642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
    Majumdar ID; Weber HC
    Handb Exp Pharmacol; 2012; (209):405-32. PubMed ID: 22249826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.
    Ohki-Hamazaki H; Watase K; Yamamoto K; Ogura H; Yamano M; Yamada K; Maeno H; Imaki J; Kikuyama S; Wada E; Wada K
    Nature; 1997 Nov; 390(6656):165-9. PubMed ID: 9367152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
    Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML
    Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E816-24. PubMed ID: 20807840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.